HLHo Jung Lee

Ho Jung Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ho Jung Lee has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Autophagy Suppresses Toll‐Like Receptor 3‐Mediated Inflammatory Reaction in Human Epidermal Keratinocytes

    by Xue Mei Li, Kyung Eun Jung, Su Hyuk Yim, Dong Kyun Hong, Chang Deok Kim, Jeong Yeon Hong, Ho Jung Lee, Sung Yul Lee, Jung Eun Kim, Chang Wook Park

    Autophagy, one mechanism of programmed cell death, is fundamental to cellular homeostasis. Previous studies have identified autophagy as a novel mechanism by which cytokines control the immune response. However, its precise role in immune‐related inflammatory skin diseases such as psoriasis remains unclear. Thus, this study explored the functional role of autophagy in psoriatic inflammation of epidermal keratinocytes. Strong light chain 3 immunoreactivity was observed in epidermal keratinocytes of both human psoriatic lesions and imiquimod‐induced mice psoriatic model, and it was readily induced by polycytidylic acid (poly (I:C)), which stimulates Toll‐like receptor 3 (TLR3), in human epidermal keratinocytes in vitro. Rapamycin‐induced activation of autophagy significantly reduced poly (I:C)‐induced inflammatory reaction, whereas, inhibition of autophagy by 3‐methyladeine increased that. Our results indicate that the induction of autophagy may attenuate TLR3‐mediated immune responses in human epidermal keratinocytes, thus providing novel insights into the mechanisms underlying the development of inflammatory skin diseases including psoriasis.


  • Open Access

    Experimental Investigation on the Tissue Response Induced by Face-Lifting Mesh Suspension Thread in Rats

    by Jung Eun Kim, Yo Han Kim, A Young Park, Ho Jung Lee, Jong Hun Lee

    Face-lifting procedures are often performed to hide the effects of aging. Thread-lifting, a minimally invasive technique for the correction of facial aging, has become increasingly popular, and various materials for the procedure have been developed. This study compared tissue responses to two types of threading sutures placed under rat skin: polypropylene (PP) monofilament mesh suspension thread (a novel face-lifting material) and polydioxanone (PDO) barbed thread. Eight rats each were assigned to the PP monofilament mesh suspension, PDO barbed thread, and control groups. Tissue reactions were evaluated 28 days after subcutaneous loading of the materials. Significant increases in tensile strength and the mean area occupied by collagen fibers were evident in skin loaded with PDO barbed thread and PP monofilament mesh suspension thread compared to control skin (p<0.05). Compared to sites loaded with PDO barbed thread, those loaded with PP monofilament mesh suspension thread showed a significant increase in the number of collagen fibers and a lower grade of inflammation (p<0.05). PP monofilament mesh suspension thread has skin-rejuvenating effects comparable to those of PDO barbed thread, but induces a less severe inflammatory response. This indicates that it is a safe and effective material for use in thread-lifting procedures on aging skin.


  • Open Access

    A Case Report of Hailey–Hailey Disease Treated with Alitretinoin

    by A Young Park, Ho Jung Lee, Euy Hyun Chung, Jung Eun Kim, Jong Suk Lee, Sang Hoon Lee, Sung Yul Lee


  • Open Access

    Association between Homocysteine Levels and Psoriasis: A Meta-Analysis

    by Jung Eun Kim, Ho Jung Lee, Jong Suk Lee, Kyu Uang Whang, Young Lip Park, Sung Yul Lee, Hyun Jung Kim

    Psoriasis is a multifactorial disease associated with an increased risk for metabolic syndrome and cardiovascular diseases. Elevated levels of homocysteine (Hcy) are a marker of cardiovascular risk. Several studies have evaluated the associations between psoriasis and Hcy levels; however, the results remain inconclusive. We performed a systematic review of the literature and a meta-analysis to better understand the relationship between psoriasis and Hcy. Five scientific databases (MEDLINE, Embase, Cochrane Library, Scopus, and Web of Science) were searched to identify relevant studies. A review of 307 publications identified 16 studies that directly assessed plasma levels of Hcy in psoriasis patients. A total of 16 studies including 2,091 subjects were included in the meta-analysis. Hcy levels were significantly higher in psoriasis patients relative to healthy controls (weighted mean difference [WMD], 3.30; 95% confidence interval [CI], 1.58∼5.02; I2=82.1%). Subgroup analyses revealed that patients with higher mean psoriasis area severity index (PASI) scores (PASI>10) had significantly higher Hcy levels compared to healthy controls (WMD, 4.17; 95% CI, 1.18∼7.16; I2=88.3%), whereas patients with lower mean PASI scores (PASI ≤10) had not (WMD, 0.76; 95% CI, −1.84∼3.35; I2=72.2%). This meta-analysis found that psoriasis patients, in particular those with PASI >10, had significantly higher Hcy levels compared to healthy controls. Further research is needed to determine the association between Hcy levels and psoriasis severity.


  • Open Access

    Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab

    by Ji Yeoun Shin, Jung Yeon Hong, Ho Jung Lee, Chang Yoon Sim, Young Lip Park, Jong Suk Lee, Sung Yul Lee, Jung Eun Kim

    Hidradenitis suppurativa (HS) is a chronic, inflammatory and painful skin disease with recurrent nodules and tracts involving the intertriginous regions. It is known that the patient with HS shows an increased risk of metabolic disorders such as diabetes, metabolic syndrome and autoimmune diseases. Klinefelter syndrome (KS) is a sex chromosomal disorder occurring in males due to an abnormality of sexual differentiation, characterized by 47, XXY karyotype. Also, KS is related with somatic comorbidities such as metabolic syndrome, autoimmune and rheumatologic disorders as HS is. We report a HS patient with KS who shows a big improvement while on tumor necrosis factor-alpha inhibitor treatment.